open access

Vol 60, No 2 (2009)
Original papers
Published online: 2009-03-27
Submitted: 2013-02-15
Get Citation

WHO fracture risk calculator (FRAX™) in the assessment of obese patients with osteoporosis

Edward Franek, Hanna Wichrowska, Dariusz Gozdowski, Monika Puzianowska-Kuźnicka
Endokrynologia Polska 2009;60(2):82-87.

open access

Vol 60, No 2 (2009)
Original papers
Published online: 2009-03-27
Submitted: 2013-02-15

Abstract


Introduction: Recently, a new fracture risk-assessment calculator (FRAX™) has been introduced. The aim of this study was to assess its usefulness for the re-assessment of fracture risk in obese patients and re-assignment to treatment.
Material and methods: 350 obese female patients were included. In all of them, 10-year fracture risk was calculated using FRAX™ (with and without T score value).
Results: If major osteoporotic fracture risk was calculated with BMD, it was low in most of the patients (in 82.1% of those treated, and in 95.9% of those not treated it was below 10%). Mean risk values were significantly higher in the treated (7.7 [3;39]%) than in the non-treated group (4.6 [2.1;14]%). The reason for start of treatment in 95 out of 106 patients was a sustained low-energy fracture, low BMD, or both.
Conclusions: The WHO fracture risk calculator may be a useful tool in treated obese females with osteoporosis. The information regarding 10-year fracture risk may change the treatment strategy at least for those in whom the decision of treatment was based solely on low BMD.

Abstract


Introduction: Recently, a new fracture risk-assessment calculator (FRAX™) has been introduced. The aim of this study was to assess its usefulness for the re-assessment of fracture risk in obese patients and re-assignment to treatment.
Material and methods: 350 obese female patients were included. In all of them, 10-year fracture risk was calculated using FRAX™ (with and without T score value).
Results: If major osteoporotic fracture risk was calculated with BMD, it was low in most of the patients (in 82.1% of those treated, and in 95.9% of those not treated it was below 10%). Mean risk values were significantly higher in the treated (7.7 [3;39]%) than in the non-treated group (4.6 [2.1;14]%). The reason for start of treatment in 95 out of 106 patients was a sustained low-energy fracture, low BMD, or both.
Conclusions: The WHO fracture risk calculator may be a useful tool in treated obese females with osteoporosis. The information regarding 10-year fracture risk may change the treatment strategy at least for those in whom the decision of treatment was based solely on low BMD.
Get Citation

Keywords

Osteoporosis; fracture; 10-year fracture risk; FRAX™

About this article
Title

WHO fracture risk calculator (FRAX™) in the assessment of obese patients with osteoporosis

Journal

Endokrynologia Polska

Issue

Vol 60, No 2 (2009)

Pages

82-87

Published online

2009-03-27

Bibliographic record

Endokrynologia Polska 2009;60(2):82-87.

Keywords

Osteoporosis
fracture
10-year fracture risk
FRAX™

Authors

Edward Franek
Hanna Wichrowska
Dariusz Gozdowski
Monika Puzianowska-Kuźnicka

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl